郑营营, 杨忠毅. The advances of clinical application of PET/CT in head and neck carcinoma[J]. China Oncology, 2017, 27(6): 425-431. DOI: 10.19401/j.cnki.1007-3639.2017.06.005.
The advances of clinical application of PET/CT in head and neck carcinoma
Head and neck carcinoma (HNC) is one of the common malignancies in the world. Because of its deep location and complicated surroundings
patients usually receive definitive radiotherapy or concurrent chemoradiotherapy. Early prediction has significant importance to guide physicians in making treatment decisions. Traditional imaging techniques have obvious limitations. However
positron emission tomography (PET)
as a non-invasive functional imaging
allows quantitative assessment of many biologic processes before the anatomic changes
such as proliferation
apoptosis and hypoxia. PET/CT is more and more widely used in HNC nowadays. This article reviewed the advances of clinical application of PET/CT in HNC in this paper
A cohort study of prognostic value of 18F-FDG PET/CT metabolic parameters in patients with diffuse large B-cell lymphoma treated with CAR-T
Value of pretreatment 18F-FLT PET/CT and 18F-FDG PET/CT uptake heterogeneity for early prediction of treatment outcome in locally advanced nasopharyngeal carcinoma
The value of18F-PSMA-1007 PET/CT in accurate assessment of newly diagnosed prostate cancer and its impact on clinical treatment decisions
The value of18F-FDG PET/CT texture analysis in predicting neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Evaluating the change of fatty acid synthesis in renal cell carcinoma by 18F-FAC microPET/CT imaging
Related Author
Shengming DENG
Bin ZHANG
Chao HE
Yeye ZHOU
Guang MA
Xiaomin OU
Chaosu HU
Shaoli SONG
Related Institution
Department of Nuclear Medicine, the First Affiliated Hospital of Soochow University
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Center for Biomedical Imaging, Fudan University; Shanghai Engineering Research Center for Molecular Imaging Probes